> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cellular, Gene Therapy Product FAQs
- URL: https://www.fdaweb.com/cellular-gene-therapy-product-faqs/
- Published: 2026-08-19T12:00:00.000Z
- Updated: 2026-09-14T12:06:07.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5161649

FDA has published a guidance, *Frequently Asked Questions—Developing Potential Cellular and Gene Therapy Products*, to help facilitate the development of safe, effective, and high-quality cellular and gene therapy (CGT) products. The [document](https://www.fda.gov/media/183631/download?ref=fdaweb.com) contains common questions directed to FDA and spans multiple disciplines, including regulatory review; chemistry, manufacturing, and controls; pharmacology/toxicology, clinical, and clinical pharmacology.

The guidance was developed, FDA says, to satisfy a PDUFA 7 commitment to increase efficiency in the development of CGT products.

The document contains an Introduction, Background, Submissions and FDA Review, Product Development Considerations, Conducting Nonclinical Studies, Conducting Human Trials, and References.